ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 247

Meager Depression Screening and Mental Health Referral Rates for Patients with Arthritis in a National Sample

Mary Margaretten1, Patricia P. Katz2, Laura Trupin2, Gabriela Schmajuk3, Jennifer Barton4, Jinoos Yazdany5 and Edward H. Yelin6, 1Rheumatology, University of California, San Francisco, San Francisco, CA, 2Medicine, UCSF, San Francisco, CA, 3Rheumatology, UCSF / San Francisco VA Medical Center, San Francisco, CA, 4Medicine, University of California, San Francisco, San Francisco, CA, 5Rheumatology, UCSF, San Francisco, CA, 6Arthritis Research Group, UCSF, San Francisco, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Depression and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Depression in patients with arthritis is common and leads to poor health outcomes. While it has been shown that rheumatologists rarely communicate about depression to their patients with arthritis, there are no data about screening practices for depression in this population. Our objectives were to describe national rates of depression screening in patients with arthritis and real-world practices for mental health referrals for patients with arthritis and prevalent depression.

Methods: In 2005 the National Ambulatory Medical Care Survey, an annual visit-based cross-sectional survey conducted in physicians’ offices, began collecting data about depression screening practices. Using 2005-2009 data, we compared office visits coded for current arthritis with other office visits to assess the rate of pre-existing depression, depression screening, and mental health referrals. Of 102,050 adult visits, we identified 14,611 coded for current arthritis (osteoarthritis and/or inflammatory arthritis) over the five-year study period. Multivariate logistic regression adjusted for age, race, and gender determined the independent association of depression and arthritis. Patients with a current diagnosis of depression were excluded from analyses of depression screening practices leaving 12,457 patient visits without depression. The chi-square test of association was used to compare depression screening practices, provider characteristics, and referral rates for mental health services between patients with and without arthritis. Patients with and without arthritis who had a current diagnosis of depression (n=11,664) were included in analyses for mental health referrals.

Results: The odds ratio for comorbid depression in patients with arthritis was 1.5 (95% CI 1.4, 1.6) controlling for age, race, and gender. Depression screening occurred in 77 (0.6%) of the eligible 12,457 visits associated with arthritis. Patients with arthritis were less likely to have depression screening services at their office visit compared to patients without arthritis (OR .69; 95% CI .54, .87). No rheumatologists screened their patients with arthritis for depression. Patients with arthritis and depression were less likely to receive referrals for psychotherapy (OR .43; 95% CI .38, .51), mental health providers (OR .25; 95% CI .15, .42), or other mental health services (OR .41; 95% CI .33, .51) compared to patients without arthritis.

Conclusion: Ambulatory physicians in the United States, whether they are rheumatologists or primary care providers, rarely screen for depression in patients with arthritis. Furthermore, identified depressed patients with arthritis are less likely to receive referrals for mental health services. Both recognition and treatment practices need to be improved for patients with arthritis and depression in order to improve health outcomes.


Disclosure:

M. Margaretten,
None;

P. P. Katz,
None;

L. Trupin,
None;

G. Schmajuk,
None;

J. Barton,
None;

J. Yazdany,
None;

E. H. Yelin,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/meager-depression-screening-and-mental-health-referral-rates-for-patients-with-arthritis-in-a-national-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology